About the Lab

The Center for Radiopharmaceutical Sciences (CRS), headed by Prof. Dr. Roger Schibli, is a joint endeavor between the Paul Scherrer Institute and the ETH Zurich. CRS is working towards clinical application of radiopharmaceuticals based on an interdisciplinary approach involving radiochemistry, radiopharmaceutical chemistry, biochemistry, molecular biology, pharmacy and pharmacology.

CRS offer the entire spectrum of radiopharmaceutical sciences which includes radionuclide development (in close cooperation with the Laboratory of Radiochemistry at PSI), radiolabeling chemistry, lead-optimization, in vitro and in vivo assessment, pre-clinical nuclear imaging (PET and SPECT) and radionuclide therapy as well as translation of new and novel radiotracers for clinical studies (in collaboration with academic and industrial partners).